Climate Change Data

Environmental Metrics

ESG Focus Areas

• Employee health and wellbeing
• Employee training and education
• Diversity & Inclusion
• Business ethics
• Animal welfare
• Antimicrobial resistance
• Climate change
• Responsible supply chain

Environmental Achievements

• Launched VetFamily ECO Program, a sustainability focused community for veterinary clinics to exchange ideas and best practices on reducing carbon emissions and protecting biodiversity. Twenty-five member clinics signed up.
• Launched “prefilled” cartridges in Diagnostics, helping reduce waste and time in extraction processes.

Social Achievements

• Completed first stakeholder dialogue with employees, customers, investors, and the Board.
• Supported an employee's gender transition, demonstrating commitment to inclusion.
• Launched VetFamily’s co-investment program, supporting member clinics to unlock higher performance or succession plans.

Governance Achievements

• Established five main governance functions to ensure sustainability strategy implementation.
• Established a sustainability sounding board with cross-segment representation.
• Appointed a Group Sustainability Manager.

Climate Goals & Targets

Environmental Challenges

• Supply chain disruptions due to the Covid-19 pandemic and geopolitical factors (Ukraine conflict).
• Decreased usage of products for human Covid tests impacting organic growth in Diagnostics.
• Lockdowns impacting member recruitment in Veterinary Services.
• Maintaining sustainability efforts while preserving the entrepreneurial environment.

Mitigation Strategies

• Developed alternative sourcing strategies and built up inventory of raw materials and finished goods.
• Established a Supplier Code of Conduct and a supplier risk screening process.
• Implemented a climate policy and carbon measurement tool.
• Established processes for data collection and set KPIs with targets.

Supply Chain Management

Responsible Procurement

• Establishing a Supplier Code of Conduct (SCoC) and a digital self-assessment framework.

Climate-Related Risks & Opportunities

Transition Risks

• Stricter regulations on environmental matters resulting in increased costs.

UN Sustainable Development Goals

• 3.4
• 5.1
• 5.5
• 8.5
• 8.8
• 10.2
• 12.2
• 12.5
• 13.2
• 13.3
• 16.5

Vimian's initiatives contribute to these goals through various programs and practices related to health, wellbeing, diversity, inclusion, responsible supply chains, climate change, and anti-corruption.

Sustainable Products & Innovation

• AeroCollect (air sampling technology)
• 3D printed orthopedic implants

Environmental Metrics

ESG Focus Areas

• People
• Animals
• Planet

Environmental Achievements

• Measured baseline of scope 1&2 emissions to 1,793 tCO2e.
• 86% of Vimians in purchasing positions trained in Supplier Code of Conduct

Social Achievements

• More than 11,000 veterinary professionals trained during the year.
• 45% of leaders are women
• 37 nationalities represented across the Group
• 67% of colleagues participated in live ethics trainings.

Governance Achievements

• New sustainability strategy approved by the Board and governance function established
• Appointed Group Sustainability Manager
• Integrated sustainability into all four segment’s business plans
• Developed foundational ESG policy framework

Climate Goals & Targets

Environmental Challenges

• Stricter regulations and demand for ESG transparency
• Unmanaged negative impacts through own operations or supplier’s operations on human rights, animal rights, the environment or ethical governance
• Ensuring safety of employees in production/warehouse and health of employees in relation to mental and physical wellbeing
• Employee retention
• Product safety for animal welfare
• Increased demand for ethically sourced, produced and low carbon products
• Delayed progress to transition towards net-zero climate impact due to unavailability of renewable energy
• Costs and availability associated with low carbon products from core sectors
• Increased exposure to extreme weather/natural disasters

Mitigation Strategies

• Increased transparency of Vimian’s ways of working through foundational policies and code of conducts
• Preparing Vimian to report according to CSRD requirement and ESRS standards during 2023/24
• Continuously drive awareness, guidance and training of the importance of business ethics
• Implement Supplier Code of Conduct, a supplier risk screening process and a pragmatic system for supplier audits
• Continuously integrate ESG risk and opportunity assessment as part of M&A due diligence process
• Reinforce a zero vision for accidents and continuously work to improve mitigation efforts
• Continuously monitor accidents, sick leave and employee experience
• Assign resource (Head of People) centrally to establish necessary actions to ensure employee satisfaction, training and development
• Update Diversity and inclusion policy and train employees
• Each entity within the Vimian Group operates a fit-for-purpose quality assurance function
• Establishing reduction targets in scope 1 and 2 emissions and initiating measures in scope 3
• Conduct a cost vs benefit analysis to commit to SBTi
• Local sites exposed to higher extreme weather/natural disaster risk to develop contingency plans
• Increase transparency of Vimian’s ways of working to reduce negative impacts on the planet
• Increase transparency in sourcing through implementing Supplier Code of Conduct in contracts
• Review products and solutions with the highest potential to transition to more sustainable packaging, ingredients, and transportation
• Identifying which sites where a transition to renewable resources would have the highest impact

Supply Chain Management

Responsible Procurement

• Supplier code of conduct (SCoC) for new suppliers with annual spend >50,000 EUR

Climate-Related Risks & Opportunities

Physical Risks

• Extreme weather events (heat, flooding, storms)

Transition Risks

• Stricter regulations
• Carbon pricing
• Increased demand for low-carbon products
• Unavailability of renewable energy

UN Sustainable Development Goals

• 3.4
• 8.8
• 8.5
• 5.1
• 5.5
• 10.2
• 3.d.2
• 15.a
• 13.2
• 13.3
• 12.2
• 12.5
• 16.5

The report mentions alignment with several SDGs, but lacks detailed explanations of how specific initiatives contribute to each goal.

Sustainable Products & Innovation

• Next generation allergy tests (PAX)
• Allergy vaccines
• 3D printed orthopedic implants
• Parasite testing with AI (OvaCyte™)

Environmental Metrics

ESG Focus Areas

• People
• Animals
• Planet

Environmental Achievements

• Launched carbon reduction plan for scope 1 and 2.
• First spend-based estimate of scope 3 emissions (78,270 tCO2e).

Social Achievements

• Launched first group-wide employee survey with 79% response rate and 32 eNPS.
• Appointed a Chief People Officer to enhance people development and experience.
• Launched new employee wellbeing program in MedTech.

Governance Achievements

• Elevated ESG rating to ‘A’ by MSCI.
• Implemented ESG due diligence process in mergers and acquisitions.
• Integrated ESG risk assessment into the annual Enterprise Risk Management process.

Climate Goals & Targets

Environmental Challenges

• Slower uptake in the transfer of volumes to the new PAX allergy test in the US.
• Challenging conditions in the livestock market with fewer disease outbreaks and lower levels of testing.
• US patent litigation.

Mitigation Strategies

• Commercial initiatives launched in Q3 and Q4 to regain momentum in the US allergy business.
• Developed alternative sourcing strategies to mitigate supply chain disruptions.
• Reached a settlement worth USD 70 million (EUR 64.7 million) in the US patent litigation.

Supply Chain Management

Supplier Audits: 43% of material suppliers assessed against Supplier Code

Responsible Procurement

• Supplier Code of Conduct

Climate-Related Risks & Opportunities

Physical Risks

• Extreme weather

Transition Risks

• Carbon pricing and future environmental taxation

Reporting Standards

Frameworks Used: GRI, EU Corporate Sustainability Reporting Directive (CSRD)

Certifications: ISO 9001, ISO 14001, GMP, GDP

Third-party Assurance: Grant Thornton Sweden AB

Sustainable Products & Innovation

• Clorexyderm product line
• HyProtect coated orthopedic implants
• PAX allergy test
• AI enabled diagnostics platform